Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

Related Keywords

Mexico ,Philippines ,Indonesia ,India ,Pune ,Maharashtra ,Richard Hatchett ,Laura Keenan Lindsey ,Erika Schultz ,Stanleyc Erck ,Alexandra Roy ,Ali Chartan ,Seth Berkley ,Adar Poonawalla ,Instagram ,Serum Institute Of India Pvt Ltd ,Linkedin ,Twitter ,World Health Organization ,Prnewswire Novavax Inc ,Vaccine Alliance ,Coalition For Epidemic Preparedness Innovations ,Nasdaq ,Exchange Commission ,Serum Institute Of India Pvt ,European Medicines Agency ,Serum Institute ,Facebook ,Novavax Inc ,Emergency Use Listing ,Chief Executive Officer ,Epidemic Preparedness Innovations ,Use Listing ,New England Journal ,Recombinant Spike Protein ,Emergency Use Authorization ,India Pvt ,Financial Condition ,Novavax Annual Report ,Quarterly Reports ,Keenan Lindsey ,Novavax ,Nc ,